Fig. 5From: Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management programMean total cost per patient from the societal perspective accrued in 6-months intervals before and during study (167 patients with cost data at visits 1, 3 and 5); adherent vs. non-adherent patientsBack to article page